Chronolife
Chronolife is a healthcare company, headquartered in France.
Entry
2017
Hold
8yr
Exit
2025
Est. EV
–
Who owns Chronolife?
Chronolife was owned by Ibionext through iBionext Growth Fund (2018 vintage) from 2017 to 2025, exited via Liquidation.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Exit Type
Liquidation
Buyer
MOIC
–
Exit Year
2025
More from iBionext Growth Fund
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Data refreshed weekly · Sourced from public filings